Alfonso Quintas Cardama
CIK: 0001760104
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
FHTX
Foghorn Therapeutics Inc.
Officer
Discretionary Trading P&L
Holdings
About Cardama Alfonso Quintas
Cardama Alfonso Quintas (SEC CIK 0001760104) files insider reports with the SEC as Chief Medical Officer of Foghorn Therapeutics Inc. (FHTX).
Signal8 holds 2 ownership filings by Cardama Alfonso Quintas, all Form 4s, filed between Jan 24, 2025 and Feb 2, 2026. Those filings report 2 transactions, from Jan 22, 2025 to Jan 30, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Cardama Alfonso Quintas's filings is in WATERTOWN, MA.
Recent filings by Cardama Alfonso Quintas
Other insiders filing for Foghorn Therapeutics Inc. (FHTX)
- BVF PARTNERS L P/IL, 10% Owner
- Lynch Thomas J. Jr., Director
- Duty Stuart, Director
- Biller Scott, Director
- Gallagher Neil, Director
- Mendelsohn Michael, Director